Aanyas Pharmaceuticals India Private Limited
About Aanyas Pharmaceuticals India Private Limited
Data last updated:
Aanyas Pharmaceuticals India Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U51909CT2016PTC007670. Its GSTIN is 22AAXCS9306B1ZA (Chhattisgarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Serum Pharmaceuticals India Private Limited. It is led by directors Rahul Dwivedi and Sonal Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. 01/13 Sector – 1 Agrasen Nagar Agroha Society Raipura, Chhattisgarh, India – 492001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.73 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹15.92 Lakh (net margin 9.2%) and EBITDA of ₹25.79 Lakh (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aanyas Pharmaceuticals India Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBlock No. 01/13 Sector – 1 Agrasen Nagar Agroha Society Raipura, Chhattisgarh, India – 492001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Aanyas Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aanyas Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aanyas Pharmaceuticals India Private Limited, buy the company report.
Financials of Aanyas Pharmaceuticals India Private Limited
FY 2025 filings availableAanyas Pharmaceuticals India Private Limited reported revenue of ₹1.73 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 4% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | 9.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aanyas Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Aanyas Pharmaceuticals India Private Limited
Aanyas Pharmaceuticals India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Dwivedi | Director | 16 Dec 2016 | 9 Years 10 Months | Current |
| Sonal Dwivedi | Director | 16 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Aanyas Pharmaceuticals India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vin Arx Pharmaceuticals Private Limited | ₹1.75 Cr (FY 2025) | 197.0% | Panchkula, Haryana, India | |||
| Shrijan Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2024) | 11.0% | Uttar Pradesh, India | |||
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Aanyas Pharmaceuticals India Private Limitedthis company | ₹1.73 Cr (FY 2024) | ₹15.92 Lakh | 9.2% | 4.0% | Raipur, Chhattisgarh, India | |
| Abhyuday Pharmaceuticals Private Limited | ₹1.72 Cr (FY 2025) | 27.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Aanyas Pharmaceuticals India Private Limited, buy the company report.
Auditor
Aanyas Pharmaceuticals India Private Limited is audited by PRADEEP K KESHARIYA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRADEEP K KESHARIYA & ASSOCIATES | FY 2017 | 077336 |
Shareholding
The shareholding of Aanyas Pharmaceuticals India Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aanyas Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aanyas Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aanyas Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aanyas Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAXCS9306B1ZA | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aanyas Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Aanyas Pharmaceuticals India Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Rahul Dwivedi was appointed as Director on 16 Dec 2016.
Frequently asked questions
Aanyas Pharmaceuticals India is an active private limited company based in Raipur, Chhattisgarh, India. The company works in specialty, within the trading industry. It was incorporated on 16 December 2016 (10+ years old) and is registered under CIN U51909CT2016PTC007670.
Aanyas Pharmaceuticals India has 2 current directors:
- Rahul Dwivedi - Director
- Sonal Dwivedi - Director
The latest financial statements of Aanyas Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Aanyas Pharmaceuticals India is 22AAXCS9306B1ZA, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Aanyas Pharmaceuticals India is U51909CT2016PTC007670. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aanyas Pharmaceuticals India was incorporated on 16 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Aanyas Pharmaceuticals India by revenue are Vin Arx Pharmaceuticals Private Limited, Shrijan Pharmaceuticals Private Limited, Sandmartin Pharmaceuticals Private Limited, Abhyuday Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rahul Dwivedi was appointed as Director on 16 Dec 2016. Sonal Dwivedi was appointed as Director on 16 Dec 2016.
The registered office of Aanyas Pharmaceuticals India is at Block No. 0113 Sector – 1 Agrasen Nagar Agroha Society Raipura, Chhattisgarh, India – 492001.
Aanyas Pharmaceuticals India operates in the trading industry, in the specialty segment.
The compliance status of Aanyas Pharmaceuticals India is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
